| Name | Title | Contact Details |
|---|
Phoenix Bio-Tech Corp is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In the simplest sense, we`re a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers.
STAT PADS is a Boise, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.
Founded in 2011, Invictus Medical is a privately owned Delaware “C” Corporation with headquarters in San Antonio, Texas. Currently, we are in the latter stages of developing our award-winning cranial support technology into our first product for commercialization. To secure early healthy development in newborns by providing innovative products, services, and solutions to the healthcare professional and consumer markets. Invictus Medical is committed to providing safe and effective medical products and high levels of service to the healthcare and consumer markets.